Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Biliary Tract Cancer Patients With Peritoneal Metastases

NCT05285358 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT05285358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05285358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Biliary Tract Cancer Patients With Peritoneal Metastases
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Recruiting
Start date
September 19, 2022
Completion date
October 11, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

distal bile duct adenocarcinoma, gallbladder carcinoma, intrahepatic cholangiocarcinoma, metastatic malignant neoplasm in the peritoneum, stage iv distal bile duct cancer ajcc v8, stage iv intrahepatic bile duct cancer ajcc v8, stage iv intrahepatic cholangiocarcinoma ajcc v8, stage ivb gallbladder cancer ajcc v8